$CYIO - New On-Line Marketing of CBD and Hand Sanitizer

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
138
$CYIO - New On-Line Marketing of CBD and Hand Sanitizer products for keeping us safe and healthy.

CYIOS Corp's Wholly Owned Subsidiary Choice Wellness Officially Launches New Online Store for Its DR's CHOICE CBD and "24" Hand Sanitizer Brands

Aventura, Florida--(Newsfile Corp. - June 19, 2020) - CYIOS Corp (OTC Pink: CYIO), a publicly traded company focused on developing and marketing specialty branded products in the Health and Wellness markets, is pleased to announce it has launched its new online-retail web platform at www.choicewellnessbrands.com. Concurrent with the launch is a social media and marketing campaign aimed at product awareness and driving traffic to the site. The Company will also be utilizing the Cicero Transact data base as part of its ongoing marketing plans.

Mr. O'Shea Chiarman of CYIOS Corp. commented, "We are very pleased to have launched our new online retail store and happy to report the expansion of our product offerings to include; DR's CHOICE brand of CBD topicals and tinctures, 24 HAND SANITIZER, and other wellness products including KN-95 face masks, infrared non-contact hand held thermometer, and soon to be released Personal Protection Equipment including Level 1 Isolation Gowns, Full Face plastic shields for medical professionals and Doctors on the front line. The first run of our 24 HAND SANITIZER will be packaged in 2oz tubes at a FDA registered facility that will also be handling all of our fulfillment with anticipated shipping availability in 1-2 weeks. Sales have already commenced with some larger orders and we are confident our new products, new online store and product marketing efforts will generate strong interest from retail consumers and from various industries seeking better and more effective sanitizing solutions.


"24" Hand Sanitizer

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7058/58...01full.jpg

The Problem in a pandemic is that harmful germs are everywhere, and consumers need to be educated that alcohol-based sanitizer is not the best long-term solution. Alcohol-based sanitizer products provide a one-time kill and only last for 1-2 minutes per use or until hands have dried. Once dried, you have no further protection against harmful germs and re-contamination as you venture out in public, head to work, and/or conduct daily routine. Alcohol can be absorbed into skin and is toxic if ingested which is not good if you have children to protect. Alcohol sanitizer stings if there is any skin abrasion on hands and must be used over and over all day, every day to combat germs while out in public. Typical thick alcohol sanitizer gel takes longer to dry, dries out skin and changes your skin's natural PH.

The Solution: 24 HAND SANITIZER kills 99.99% of germs, is alcohol-free and formulated & enhanced with Zetrisil®. Zetrisil® is a nano antimicrobial technology that creates a shield of protection on your hands and provides persistent long-lasting protection that helps prevent re-contamination of harmful germs that your hands may come into contact with from your daily routine, workplace and/or out in public. The fast acting, quick drying formula leaves hands soft and smooth, is safe for children and contains NO ALCOHOL = Non flammable, Non-toxic AND NO STING! Importantly, 24 is more economical than traditional alcohol-based products due to lower overall usage need per day and per month. AND, it's MADE IN THE USA!

Mr. O'Shea went on to say, "Unlike alcohol based sanitizer, there is some unique science behind 24 HAND SANITIZER. The physical kill of germs is accomplished by the active ingredient Benzolkonium Chloride which is one of only three (and the only one that is non-alcohol) active ingredients allowed by the FDA for use in hand sanitizer. 24 HAND SANITIZER is formulated and enhanced with Zetrisil®. Zetrisil® is a proprietary nano-based silicone compound which effectively protects and/or "shields" the area that 24 HAND SANITIZER is applied to from bacterial contamination by way of a long-lasting, cationic-charged, anti-microbial nano-silicone coating. In other words, Zetrisil® creates a shield of protection on your hands and provides persistent activity that helps prevent re-contamination of harmful germs that your hands may come into contact with in between washings, while at work, and/or while out in public. As Governments, States and Cities continue to open, giving rise to new pandemic cases, we feel it's important to offer a safer alternative to alcohol based sanitizers and to provide a hand sanitizing solution that can give people some confidence and a little peace of mind that their sanitizing regimen will do more than a one-time kill of germs, by way of providing an additional important benefit of long-lasting protection from re-contamination."

CONTACT INFORMATION
info@choicewellnessbrands.com

Investors are encouraged to follow CYIOS using:
www.twitter.com/cyioscorp
www.linkedin.com/company/cyios-corporation-llc
www.facebook.com/cyioscorporation

About ChoiceWellness, Inc:

ChoiceWellness, Inc. is a health and wellness company that has brought to market the DR's CHOICE line of products, as well as the "24" Brand Hand Sanitizer products. DR's CHOICE was developed with a mission to offer Doctors and Medical Practitioners their own Professional Grade CBD BRAND with a suite of products they could stand behind and be confident to offer to their patients. Our customers can be assured that DR's CHOICE CBD products have gone through the highest scrutiny of testing for purity, potency and quality. DR's Choice products have been brought to market for Doctors and Medical Professionals seeking a better solution for patients suffering from pain, inflammation, anxiety or other persistent symptoms. For more information please visit www.choicewellnessbrands.com

About CYIOS Corporation:

CYIOS Corporation is a publicly traded company focused developing and marketing specialty branded products in the Health and Wellness markets, including the "DR's CHOICE" and "24" brand of products. The team has in-depth knowledge of the health and wellness markets, financial services industry, medical and health services, and blockchain. The Company looks to develop, distribute, and license proprietary products as well as evaluate potential acquisition opportunities. Further, the Company continues to seek and evaluate attractive business opportunities and to leverage its resources and expertise to build a diversified, sustainable business model. For more information please visit www.cyioscorporation.com

FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements." Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" & other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered w/ these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.


To view the source version of this press release, please visit https://www.newsfilecorp.com/release/58209

https://www.newsfilecorp.com/newsinfo/58209/130
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lear Capital Hits $5 Billion Milestone: Trust or Hype?

Updated Category News Views 114

A Golden Milestone or Just Glitter? Lear Capital's announcement of surpassing $5 billion in precious metals transactions feels like one of those moments where you tilt your head and ask, "Is it really what it seems?" With nearly 150,000 customers and almost three decades of hustling in the glittering world of gold and silver, they've certainly carved out a name in the...

Continue Reading
Leadership Shake-Up at Equity LifeStyle Properties

Updated Category News Views 96

Shifting Gears at the Top When the calendar flips to 2027, Equity LifeStyle Properties, Inc. (NYSE:ELS) will be kicking off the new year with a fresh lineup at the helm. After 13 long years steering the ship, Marguerite Nader is moving into the role of Executive Vice Chair of the Board of Directors, paving the way for Patrick Waite to step into her shoes as President and...

Continue Reading
Right Heart Failure Gains Recognition as Its Own Syndrome

Updated Category News Views 54

Changing the Narrative on Right Heart Failure How often do we see right heart failure (RHF) brushed aside like some understudy in the grand play of cardiovascular disease? Far too often, according to the Heart Failure Society of America (HFSA). They're here to shift that narrative, demanding RHF be recognized for what it truly is: a distinct clinical syndrome. Forget...

Continue Reading
Small Biz Financing Soars Amid Credit Struggles

Updated Category News Views 50

Record Financing Applications, But Not All is Rosy Diving headlong into this 1West data is like clutching at a double-edged sword. On one side, we've got record-breaking numbers—48,975 financing applications in Q3 alone. That’s a staggering 25% hike over last year. But before you pop the champagne, let's pivot to the other edge: dwindling financial health. With the...

Continue Reading
Grünenthal Pushes Pain Boundaries with RISE Trial Win

Updated Category News Views 136

Grünenthal, coming straight outta Germany, is lighting up the stage at the 2026 IASP World Congress on Pain in Bangkok with some heavy-duty results from their Phase III RISE trial. We’re talking serious news for folks grappling with post-surgical neuropathic pain. Breaking Down the RISE Results Let’s cut to the chase: Qutenza®, the protagonist here, smashed through...

Continue Reading
Sodium Silicate Market To Hit $7.4B by 2031

Updated Category News Views 28

What's Fueling the Market's Climb? I tell ya, sodium silicate might not be a household name, but it's trekking upwards with a clear purpose. By 2031, this market's expected to touch $7.4 billion from $6 billion in 2026 at a neat 4.4% CAGR. For an old-school trader like me, that's the kind of steady growth that catches my eye. The driving factors? Well, it’s more than...

Continue Reading
McKinsey and Parloa Join Forces on AI Customer Service

Updated Category News Views 0

AI-Revolutionizing Customer Service: The New Partnership Out of the boardroom and into the trenches, McKinsey joins hands with Parloa, aiming to reshape how enterprises handle customer service through artificial intelligence. Forget all the corporate fluff you've heard before; these guys are dead set on closing the massive gap companies face in deploying AI agents...

Continue Reading
Amgen Declares Q4 Dividend Amidst Broad Horizons

Updated Category News Views 76

Amgen's Steady Dividend: A Testament to Stability Diving into the mess that is today's biotech market, Amgen (NASDAQ:AMGN) stands out like a beacon of stability with its recent dividend announcement. The Board's decision to dole out a $2.52 per share dividend for the fourth quarter of 2026 showcases confidence amidst both promising ventures and looming uncertainties....

Continue Reading
Qloo's AI Reveals Overlooked EV Market Opportunities

Updated Category News Views 99

Uncovering Surprising Market Overlaps Ever thought the guy barreling through mud in his rugged 4x4 might have more in common with an electric vehicle enthusiast than we'd usually guess? That's the curveball Qloo and Kearney are tossing at us. Their latest study shakes up the tired old assumptions floating around the automotive sector about who's buying what and why. Using...

Continue Reading
Philanthropy in Focus: Town & Country's Star-Studded Day

Updated Category News Views 77

An Annual Celebration of Generosity Town & Country, marking 180 years of observing the social highs and lows, just wrapped up its 13th Annual Philanthropy Summit at Hearst Tower. This wasn't your run-of-the-mill event where you sit and awkwardly sip bad coffee. When you've got high-profile names like Tory Burch and Russell Wilson in the same room, you know it’s a...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Trading Disclosure from Dowlais Group plc Exempt Trader

Updated Category News Views 134

Understanding the Trading Disclosure from Dowlais Group plc The trading landscape can often seem complex, especially when it comes to understanding exemptions and deals in securities. This article aims to clarify the recent trading disclosures linked to Dowlais Group Plc as reported by an exempt principal trader, specifically Investec Bank plc. Key Information Regarding...

Continue Reading
What to Expect from SES AI's Upcoming Earnings Report

Updated Category News Views 106

SES AI's Earnings Report Insights As SES AI (NYSE: SES) gears up for its upcoming quarterly earnings announcement, investors are keenly observing the developments. While the exact announcement date is yet to arrive, the anticipation among stakeholders is tangible. Analyst Expectations The consensus from analysts indicates an anticipated earnings per share (EPS) of $-0.12...

Continue Reading
Understanding Western Asset Emerging Markets Debt Fund's Distributions

Updated Category News Views 117

Western Asset Emerging Markets Debt Fund Inc. (NYSE: EMD) made waves back in 2024 when it laid out the nitty-gritty of its monthly distributions, and let me tell ya, traders were paying close attention. They announced a total distribution per share of $0.0845 for September—a number that had desks buzzing with anticipation and caution. Distribution Breakdown: Cash Flow...

Continue Reading
Understanding Voting Rights within Octopus AIM VCT plc

Updated Category News Views 274

Insights into Total Voting Rights and Share Capital Octopus AIM VCT plc is an essential part of the investment landscape, and understanding its total voting rights and share capital is crucial for stakeholders. This company has recently announced its current share structure and voting rights available to its shareholders. This information is not only vital for governance...

Continue Reading
Regional Banks Adapt as Fed Cuts Provide Breathing Room

Updated Category News Views 122

Understanding the Impact of Federal Reserve Rate Cuts on Regional Banks U.S. regional banks are currently navigating a landscape marked by increasing capital requirements while also experiencing some relief due to significant rate cuts by the Federal Reserve. These changes aim to address the weaknesses that recently led to the failure of several regional banks, creating a...

Continue Reading